Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

NCT02016430 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT02016430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02016430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
April 4, 2014
Completion date
December 31, 2026
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, dietary modification